1kits(10Vials)
| Availability: | |
|---|---|
| Quantity: | |
▎What is Adamax?
Adamax is a synthetic neuropeptide biopharmaceutical derived from the cycloalkyl modification of Sema, combining the activities of Sema and P21 for neuroprotection and cognitive enhancement.
▎Adamax Structure
Source: PepDraw | Sequence: Ac-Met-Glu-His-Phe-Pro-Gly-Pro-Ala-Gly-OH Molecular Formula: C22H52N16O6 Molecular Weight:1032.24 g/mol |
▎Adamax Research
What is the research background of Adamax?
Adamax emerged from the need for highly effective anti-inflammatory and tissue repair agents with optimized drug stability. With rising incidence rates of chronic inflammatory diseases and tissue injury conditions, traditional treatments face limitations such as slow onset of action. Additionally, biological agents are prone to inactivation by environmental factors, restricting clinical application. Researchers urgently sought active substances capable of precisely modulating cellular signaling pathways, combining anti-inflammatory and reparative functions while enhancing drug stability. Adamax delivers targeted regulation and functional enhancement.
What is Adamax's mechanism of action?
As a synthetic peptide mimicking activity-dependent neuroprotective protein (ADNP), it interacts with microtubule-end-binding proteins to enhance microtubule assembly and stability, thereby improving neuronal survival and synaptic plasticity. It significantly upregulates the release of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), increases hippocampal TrkB receptor sensitivity, activates the TrkB/ERK pathway, and inhibits excessive GSK-3β phosphorylation. This produces multiple neuroprotective effects including antioxidant activity, anti-inflammation, and reduction of β-amyloid deposition.
What are the applications of Adamax?
Adamax enhances learning, memory retention, and recall by promoting synaptic plasticity between the hippocampus and cerebral cortex. It prevents and delays Alzheimer's disease by reducing β-amyloid plaque deposition and tau hyperphosphorylation. In models of autism and fragile X syndrome, it improves social and cognitive deficits. By modulating 5-HT and DA systems, it exerts anxiolytic and antidepressant effects. Its antioxidant, anti-inflammatory, and anti-toxic properties counteract oxidative stress and inflammatory damage to reduce the risk of age-related cognitive decline. It also optimizes the sleep-wake cycle to improve sleep quality and duration. Adamax enhances endurance and recovery speed and is being explored for use in neuromuscular system training support for athletes.
Conclusion
Adamax exhibits excellent stability and bioavailability, primarily exerting its effects by regulating metabolic, inflammatory, and repair-related signaling pathways. It facilitates appetite suppression, improved insulin sensitivity, and lipid metabolism regulation while exhibiting immunomodulatory and tissue repair effects. With high specificity and safety, Adamax demonstrates broad application prospects in metabolic disorders, inflammatory diseases, and regenerative medicine, reflecting the trend toward precision development in peptide-based biologics.
About The Author
The above-mentioned materials are all researched, edited and compiled by Cocer Peptides.
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.
The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.